{"id":7204,"date":"2012-10-04T09:05:49","date_gmt":"2012-10-04T13:05:49","guid":{"rendered":"https:\/\/www.bumc.bu.edu\/ppb\/?page_id=7204"},"modified":"2016-05-18T17:57:59","modified_gmt":"2016-05-18T21:57:59","slug":"people","status":"publish","type":"page","link":"https:\/\/www.bumc.bu.edu\/ppb\/education\/pharmacology\/training-program\/laboratories\/wolozinlab\/people\/","title":{"rendered":"People"},"content":{"rendered":"

 <\/p>\n

\"10-3061-PHARMALABS-0028\"<\/a><\/p>\n

Principal Investigator<\/strong><\/p>\n

\"10-3061-PHARMALABS-0014\"<\/a><\/strong><\/p>\n

Benjamin Wolozin, M.D.\/Ph.D.<\/a><\/p>\n

Benjamin Wolozin completed his undergraduate education at Wesleyan University in Middletown, CT. He earned his M.D. and Ph.D. degrees from Albert Einstein College of Medicine, as part of the Medical Scientist Training Program. His postdoctoral fellowships were spent at Mt. Sinai Medical Center (1988-9) and the National Institute of Mental Health (1989\u201396). He joined Loyola University Medical Center in 1996 as an Associate Professor and rose to the rank of tenured full professor. He joined the Department of Pharmacology & Experimental Therapeutics at Boston University School of Medicine in 2004 as a Professor and also holds a secondary appointment in the Department of Neurology.<\/p>\n

Dr. Wolozin is member of the Boston University Alzheimer\u2019s Disease Center and the Boston University Parkinson\u2019s disease and Movement Disorders Center. His interests focus on the pathophysiology of neurodegenerative diseases, including Alzheimer\u2019s disease, Parkinson\u2019s disease and Amyotrophic Lateral Sclerosis. His work on Alzheimer\u2019s disease examines the role of cholesterol in the pathophysiology of Alzheimer\u2019s disease, and stems from his discovery in 2000 that subjects taking the cholesterol-lowering medicines, termed statins, have a lower incidence of Alzheimer\u2019s disease. His work on Parkinson\u2019s disease examines the interaction between genes implicated in the disease, such as LRRK2 and alpha-synuclein, and environmental factors implicated in the disease. His work on ALS focuses on the response of RNA metabolism and protein translation to stress. He uses multiple approaches to study neurodegenerative disease, ranging from molecular approaches to epidemiology. These approaches include molecular biology, cellular biology, transgenic mice, transgenic C. elegans, study of human brain samples and epidemiological database analyses.<\/p>\n

At present, Dr. Wolozin serves as the primary investigator for several funded studies including, LRRK2 and Neurodegeneration, Interaction between genes and mitochondria in Parkinson\u2019s disease, Stress granules and the biology of TDP-43, Development of Opticogenetic switches for mitochondrial function, and LRRK2 interactions with pathways linked to protein folding and degradation.<\/p>\n

Dr. Wolozin has received numerous awards for his research including the Donald B. Lindsley Prize, Society for Neuroscience, the A. E. Bennett Award and a Merit Award from Alzforum. He is a member of the Scientific Advisory Board for Proteotech Pharmaceuticals and CMD Bioscience LLC, and is on the executive board for the Committee for Skeptical Inquiry. He also serves on numerous editorial boards, including the Journal of Biological Chemistry and Neurodegenerative Diseases, and is a standing member of the NIH CMND study section.<\/p>\n

 <\/p>\n

CURRENT LABORATORY STAFF<\/b><\/p>\n

Post-Doctoral Fellows<\/strong><\/p>\n\n\n\n\n\n
\"Peter<\/a><\/td>\nPeter Ash, PhD<\/a><\/p>\n
    \n
  • Research:<\/em><\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
\"Heather's<\/a>
\n<\/a><\/td>\n		Heather Ballance PhD<\/a><\/p>\n
    \n
  • Research:<\/em><\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n

Graduate Students<\/strong><\/p>\n\n\n\n\n\n\n
\"Apicco<\/a><\/strong><\/td>\nDaniel Apicco<\/p>\n
    \n
  • PhD Biomolecular Pharmacology\/Biomedical Neuroscience<\/li>\n
  • Research:<\/em>\u00a0Understanding the intersection biology of tau and RNA binding proteins associated with stress granules in Alzheimer’s disease and other tauopathies.<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
\"Maziuk<\/strong><\/td>\nBrandon Maziuk<\/p>\n
    \n
  • PhD Biomolecular Pharmacology<\/li>\n
  • Research: <\/em>Understanding the cellular and molecular biology underlying neurodegenerative diseases, particularly Alzheimer’s disease<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n

Master’s Students<\/strong><\/p>\n\n\n\n\n
<\/td>\n<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n

Laboratory Technician<\/strong><\/p>\n

\"Ali<\/a>Ali Al Abdullatif, Research Assistant<\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

Undergraduate Students<\/strong><\/p>\n\n\n\n\n\n\n
\"Bria<\/a><\/td>\nBria Adams<\/td>\n<\/tr>\n
\"Brandon<\/a><\/td>\nBrandon\u00a0Bedell<\/td>\n<\/tr>\n
\"Emily<\/a><\/td>\nEmily Botelho<\/td>\n<\/tr>\n
\"IMG_2347\"<\/a><\/td>\nAmanda Jeh<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n

LABORATORY ALUMNI<\/strong><\/p>\n

Former Postdoctoral Fellows<\/strong><\/p>\n\n\n\n\n\n
<\/td>\n<\/td>\n<\/tr>\n
\"Liu-Yesucevitz<\/a><\/td>\nLiQun Liu, PhD<\/p>\n
    \n
  • Current Position<\/em>: Clinical Trial Manager, The Center for Computation and Integrative Biology, Massachusetts General Hospital<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
\"Katherine_Youmans\"<\/a><\/td>\nKatie Youmans-Kidder, PhD<\/p>\n
    \n
  • Current Position:<\/em>\u00a0Medical Science Liaison, Teva Pharmaceuticals<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

    Former Graduate Students<\/strong><\/p>\n\n\n\n\n\n\n
    \"Boon<\/a><\/td>\nJoon Ying Boon, PhD<\/td>\n<\/tr>\n
    \"aebata\"<\/a><\/td>\nAtsushi Ebata, PhD<\/p>\n
      \n
    • Current Position:<\/em>\u00a0Consultant, Boston Technology Research Corporation<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
    \"Trengrove_Chelsea_U159711242-150x150\"<\/a><\/td>\nChelsea Trengrove, PhD<\/p>\n
      \n
    • Current Position:<\/em>\u00a0Project Manager, Boston Technology Research Corporation<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
    \"Vanderweyde<\/a><\/td>\nTara Vanderweyde, PhD<\/p>\n
      \n
    • Current Position:<\/em>\u00a0Scientist, Aquinnah Pharmaceuticals<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

      Former Masters Students<\/strong><\/p>\n\n\n\n\n
      <\/a>\"brown.bike\"<\/a><\/td>\nIsaac Goldszer<\/p>\n
        \n
      • Current Position:<\/em>\u00a0M.D. Candidate (2018), Florida Atlantic University<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
      <\/td>\nVivek Gowda<\/p>\n
        \n
      • Current Position:<\/em>\u00a0Researcher, Harvard Medical School<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

        Senior Research Scientists<\/strong><\/p>\n\n\n\n
        \"Saha\"<\/a><\/a><\/td>\nShamol Saha, PhD<\/p>\n
          <\/ul>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

          Former Lab Staff\u00a0<\/strong><\/p>\n\n\n\n
          \"Citro-150x150\"<\/a><\/td>\nAllison Citro<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

          Former Undergraduates<\/strong><\/p>\n\n\n\n\n\n
          \"Hentschel\"<\/a><\/td>\nAlexander Hentschel<\/td>\n<\/tr>\n
          \"SONY<\/a><\/td>\nMaria Iuliano<\/p>\n
            \n
          • Current Position<\/em>: Research Technician, Massachusetts General Hospital<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n
          <\/td>\n<\/em><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

           <\/p>\n

          \u00a0<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

            Principal Investigator Benjamin Wolozin, M.D.\/Ph.D. Benjamin Wolozin completed his undergraduate education at Wesleyan University in Middletown, CT. He earned his M.D. and Ph.D. degrees from Albert Einstein College of Medicine, as part of the Medical Scientist Training Program. His postdoctoral fellowships were spent at Mt. Sinai Medical Center (1988-9) and the National Institute of […]<\/p>\n","protected":false},"author":6226,"featured_media":0,"parent":7193,"menu_order":1,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/www.bumc.bu.edu\/ppb\/wp-json\/wp\/v2\/pages\/7204"}],"collection":[{"href":"https:\/\/www.bumc.bu.edu\/ppb\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.bumc.bu.edu\/ppb\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/ppb\/wp-json\/wp\/v2\/users\/6226"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/ppb\/wp-json\/wp\/v2\/comments?post=7204"}],"version-history":[{"count":52,"href":"https:\/\/www.bumc.bu.edu\/ppb\/wp-json\/wp\/v2\/pages\/7204\/revisions"}],"predecessor-version":[{"id":12246,"href":"https:\/\/www.bumc.bu.edu\/ppb\/wp-json\/wp\/v2\/pages\/7204\/revisions\/12246"}],"up":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/ppb\/wp-json\/wp\/v2\/pages\/7193"}],"wp:attachment":[{"href":"https:\/\/www.bumc.bu.edu\/ppb\/wp-json\/wp\/v2\/media?parent=7204"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}